NCT03545568View on ClinicalTrials.gov

Sialic Acid Supplementation in N-Acetylneuraminic Acid Synthase (NANS) Deficiency

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

October 15, 2018

Study Completion Date

October 15, 2018

Conditions
N-Acetylneuraminic Acid Storage Disease
Interventions
OTHER

Neu5Ac supplementation

Sialic acid as N-Acetyl-neuraminic acid dehydrate (Neu5Ac) 150 mg/kg/d (max 12g/d) in three doses orally in subjects with NANS deficiency compared to controls

Trial Locations (2)

1011

Lausanne University Hospital, Lausanne

42123

Struttura Semplice Dipartimentale di Genetica Clinica, Reggio Emilia

All Listed Sponsors
collaborator

University of Modena and Reggio Emilia

OTHER

lead

University of Lausanne

OTHER

NCT03545568 - Sialic Acid Supplementation in N-Acetylneuraminic Acid Synthase (NANS) Deficiency | Biotech Hunter | Biotech Hunter